Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136)

C. C. Chang, M. H. Yang, B. R. Lin, S. T. Chen, S. H. Pan, M. Hsiao, T. C. Lai, S. K. Lin, Y. M. Jeng, C. Y. Chu, R. H. Chen, P. C. Yang, Y. Eugene Chin*, M. L. Kuo

*Corresponding author for this work

Research output: Contribution to journalComment/debate

2 Scopus citations

Abstract

Following publication of their article “CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation”, the authors reported an error in Fig.6b. α-Tubulin image of rCCN2 treatment (upper panel in CL1-5) only showed eight lanes, when there should be nine.

Original languageEnglish
Pages (from-to)196
Number of pages1
JournalCell Death and Differentiation
Volume26
Issue number1
DOIs
StatePublished - 1 Jan 2019

Fingerprint

Dive into the research topics of 'Correction to: CCN2 inhibits lung cancer metastasis through promoting DAPK-dependent anoikis and inducing EGFR degradation (Cell Death & Differentiation, (2013), 20, 3, (443-455), 10.1038/cdd.2012.136)'. Together they form a unique fingerprint.

Cite this